Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuya Xiao

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|August 5, 2024
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Journal of the American Medical Directors Association|October 6, 2024
Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort StudyHemalkumar B Mehta, Xuya Xiao, Huijun An, et al.
Pharmacotherapy|August 4, 2023
Potential drug-drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross-sectional study of the National Covid Cohort Collaborative (N3C)Xuya Xiao, Hemalkumar B Mehta, Jill Curran, et al.
Obesity (Silver Spring, Md.)|November 21, 2025
Weight Changes From Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort StudyG Caleb Alexander, Yizhen Xu, Xuya Xiao, et al.
Critical Care Medicine|June 3, 2025
The authors replyAsad E Patanwala, Xuya Xiao, Thomas E Hills, et al.
Critical Care Medicine|October 4, 2024
Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid CollaborativeAsad E Patanwala, Xuya Xiao, Thomas E Hills, et al.
JAMA Internal Medicine|March 2, 2026
Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-AnalysisG Caleb Alexander, Xuya Xiao, Sophie Dilek, et al.
Journal of General Internal Medicine|June 30, 2025
US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed TherapyG Caleb Alexander, Jill Curran, Alejandro Victores, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Plos Medicine|January 17, 2025
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|August 5, 2024
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Journal of the American Medical Directors Association|October 6, 2024
Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort StudyHemalkumar B Mehta, Xuya Xiao, Huijun An, et al.
Pharmacotherapy|August 4, 2023
Potential drug-drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross-sectional study of the National Covid Cohort Collaborative (N3C)Xuya Xiao, Hemalkumar B Mehta, Jill Curran, et al.
Obesity (Silver Spring, Md.)|November 21, 2025
Weight Changes From Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort StudyG Caleb Alexander, Yizhen Xu, Xuya Xiao, et al.
Critical Care Medicine|June 3, 2025
The authors replyAsad E Patanwala, Xuya Xiao, Thomas E Hills, et al.
Critical Care Medicine|October 4, 2024
Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid CollaborativeAsad E Patanwala, Xuya Xiao, Thomas E Hills, et al.
JAMA Internal Medicine|March 2, 2026
Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-AnalysisG Caleb Alexander, Xuya Xiao, Sophie Dilek, et al.
Journal of General Internal Medicine|June 30, 2025
US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed TherapyG Caleb Alexander, Jill Curran, Alejandro Victores, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Plos Medicine|January 17, 2025
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3CAbhishek Bhatia, Alexander J Preiss, Xuya Xiao, et al.
Pageof 1